发明名称 |
CONTROLLED ACTIVATION INGESTIBLE IDENTIFIER |
摘要 |
Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc. |
申请公布号 |
US2015182463(A1) |
申请公布日期 |
2015.07.02 |
申请号 |
US201414570673 |
申请日期 |
2014.12.15 |
申请人 |
Proteus Digital Health, Inc. |
发明人 |
Hafezi Hooman;Robertson Timothy;Colliou Olivier;Zdeblick Mark |
分类号 |
A61K9/20;A61B5/00 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising:
a pharmaceutical active agent; a controlled activation identifier configured to transmit a signal upon contact with a target site of a body, wherein the controlled activation identifier comprises:
a solid support;first and second materials with dissimilar electrochemical properties located on a surface of the solid support; anda dried conductive medium precursor; and a pharmaceutically acceptable carrier. |
地址 |
Redwood City CA US |